Reviva Pharmaceuticals, Inc.
Small-molecule pharmaceuticals for CNS, cardiovascular, metabolic, and inflammatory diseases
- Sector
- Biotech
- Headquarters
- Santa Clara, CA
- Latest Form D
- $1.2M, Jul 2016
- Total capital
- $36.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $36.7M
- 4 Form D · last Jul 2016
- 123 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 15
- 25 pending · first 2014
- Rank in peer group#112 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$1.2M
- Private capital raisedForm D · SEC · 3rd filing$15.8M
- Private capital raisedForm D · SEC · 2nd filing$12M
- Private capital raisedForm D · SEC · 1st filing$7.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#112 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Laxminarayan BhatResearcherExecutive Officer, DirectorLinked by 8 patents
- Marc CantillonExecutive OfficerNamed in SEC Form D filings
- Pedr JensenDirectorNamed in SEC Form D filings
- Sarvajna DwivediDirectorNamed in SEC Form D filings
What it has protected
USPTO · 15 granted of 40- PendingBrilaroxazine Liposome CompositionUSPTOApplication 19340389
- PendingMethod For Treating PsoriasisUSPTOApplication 19340610
- GrantedMethods For Treating Pulmonary FibrosisUSPTOUS 12,053,477
Show all 40 patent records
- Brilaroxazine Liposome CompositionJan 22, 2026 · Application 19340389Pending
- Method For Treating PsoriasisJan 22, 2026 · Application 19340610Pending
- Methods For Treating Pulmonary FibrosisAug 6, 2024 · US 12,053,477Granted
- Methods For Treating Pulmonary FibrosisMay 6, 2021 · Application 17143872Pending
- Methods For Treating Pulmonary HypertensionOct 15, 2019 · US 10,441,590Granted
- Methods For Treating Parkinson's DiseaseMay 16, 2019 · Application 16247407Pending
- Compositions, Synthesis, And Methods Of Using Phenylcycloalkylmethylamine DerivativesJul 31, 2018 · US 10,035,761Granted
- Arylpiperazine Derivatives And Methods Of Utilizing SameMay 22, 2018 · US 9,975,862Granted
- Methods For Treating Psychosis Associated With Parkinson’s DiseaseMar 15, 2018 · Application 15643782Pending
- Methods For Treating Alzheimer’s DiseaseMar 15, 2018 · Application 15643718Pending
- Methods For Treating Attention Deficit Hyperactivity DisorderMar 6, 2018 · US 9,907,803Granted
- Compositions, Synthesis, And Methods Of Using Phenylcycloalkylmethylamine DerivativesJul 4, 2017 · US 9,695,116Granted
- Arylpiperazine Derivatives And Methods Of Utilizing SameMar 28, 2017 · US 9,604,944Granted
- Synthesis, Methods Of Using, And Compositions Of CycloalkylmethylaminesApr 5, 2016 · US 9,302,981Granted
- CycloalkylmethylaminesMar 29, 2016 · US 9,296,681Granted
- Arylpiperazine Derivatives And Methods Of Utilizing SameFeb 9, 2016 · US 9,255,076Granted
- Compositions, Synthesis, And Methods Of Using Phenylcycloalkylmethylamine DerivativesJan 19, 2016 · US 9,238,625Granted
- Methods Of Using Cycloalkylmethylamine DerivativesAug 4, 2015 · US 9,096,515Granted
- Arylpiperazine Derivatives And Methods Of Utilizing SameMar 17, 2015 · US 8,980,883Granted
- Methods Of Utilizing Arylpiperazine DerivativesOct 14, 2014 · US 8,859,552Granted
- Synthesis, Methods Of Using, And Compositions Of CycloalkylmethylaminesMar 11, 2014 · US 8,669,285Granted
- Synthesis, Methods Of Using, And Compositions Of CycloalkylmethylaminesApplication PCTUS2007078682Pending
- Method For Treating Negative Symptoms Of SchizophreniaApplication 63734686Pending
- Brilaroxazine Liposome CompositionApplication PCTUS2024022067Pending
- Method For Treating PsoriasisApplication PCTUS2024022075Pending
- Brilaroxazin Liposome CompositionApplication 63493233Pending
- Method For Treating PsoriasisApplication 63493241Pending
- Methods For Treating Pulmonary FibrosisApplication 16913414Pending
- Methods For Treating Pulmonary FibrosisApplication PCTUS2018067999Pending
- Methods For Treating Psychosis Associated With Parkinson's DiseaseApplication PCTUS2016013069Pending
- Methods For Treating Alzheimer's DiseaseApplication PCTUS2016013061Pending
- Methods For Treating Attention Deficit Hyperactivity DisorderApplication PCTUS2015024976Pending
- Compositions, Synthesis, And Methods Of Using Phenylcycloalkylmethylamine DerivativesApplication PCTUS2012072283Pending
- Compositions, Synthesis, And Methods Of Using Cycloalkylmethylamine DerivativesApplication PCTUS2011042887Pending
- Compositions, Synthesis, And Methods Of Utilizing Arylpiperazine DerivativesApplication PCTUS2010025687Pending
- Compositions, Synthesis, And Methods Of Utilizing Quinazolinedione DerivativesApplication PCTUS2010025688Pending
- Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic AgentsApplication PCTUS2009045320Pending
- Compositions, Synthesis, And Methods Of Using Quinolinone Based Atypical Antipsychotic AgentsApplication PCTUS2008064433Pending
- Compositions, Systhesis, And Methods Of Using Indanone Based Cholinesterase InhibitorsApplication PCTUS2007025392Pending
- Method For Treating Negative Symptoms Of SchizophreniaApplication PCTUS2025059527Pending
Related companies, and why
- TEAMEDON INTERNATIONAL, INC.Similar federal contract value in Biotech · null in contracts
- Recourse Biologics, Inc.Similar federal contract value in Biotech · null in contracts
- Lyell ImmunopharmaSimilar federal contract value in Biotech · null in contracts
- Turn Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Codebreaker Tx, Inc.Similar federal contract value in Biotech · null in contracts
- VERALOX THERAPEUTICS, INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .